Ghost Tree Capital’s Genocea Biosciences, Inc. GNCA Stock Holding History

Ghost Tree Capital’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-250,000	Closed	-$1.18M	–	54
2019 Q1	$1.18M	Sell	250,000 -190,625	-43%	-$943K	0.31%	36
2018 Q4	$1.01M	Hold	440,625	–	–	0.37%	35
2018 Q3	$2.75M	Hold	440,625	–	–	0.58%	42
2018 Q2	$3.02M	Buy	+440,625	New	+$3.3M	0.89%	34
2015 Q4	–	Sell	-27,500	Closed	-$1.51M	–	81
2015 Q3	$1.51M	Sell	27,500 -6,250	-19%	-$620K	0.68%	51
2015 Q2	$3.71M	Sell	33,750 -18,750	-36%	-$1.74M	1.2%	39
2015 Q1	$4.98M	Buy	+52,500	New	+$3.7M	1.79%	18

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Ghost Tree Capital's GNCA Position: Q2 2019 in Review

Ghost Tree Capital sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2019, closing a stake of 250,000 shares — an estimated $1.18M sold.

Ghost Tree Capital first reported a position in GNCA in Q1 2015 and held it in 7 quarters. The position peaked at $4.98M in Q1 2015. 45 funds tracked by Wall St. Rank hold GNCA as of Q2 2019.

Ghost Tree Capital reported no remaining Genocea Biosciences, Inc. position as of Q2 2019 after selling out during the quarter.
Ghost Tree Capital sold 250,000 Genocea Biosciences, Inc. shares in Q2 2019, an estimated $1.18M.
Ghost Tree Capital first reported a position in Genocea Biosciences, Inc. in Q1 2015 and held it in 7 quarters.
Ghost Tree Capital's Genocea Biosciences, Inc. position peaked at $4.98M in Q1 2015.
45 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2019.

Based on Ghost Tree Capital's 13F filing for Q2 2019, filed 14 Aug 2019.